Clinical Trial Update: Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA [Phase 3]

View source ↗

Summary

Phase 3 trial comparing entecavir and tenofovir regimens in lymphoma patients with active HBV DNA; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Hbv Infection

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Tenofovir (Tenofovir)

Snippet

Sponsor: Ruijin Hospital | Conditions: B-cell Lymphoma, HBV | Phase 3 | Status: UNKNOWN